| Ident. | Authors (with country if any) | Title |
|---|
| 000091 (2021) |
Fatemeh Sadat Hosseini [Iran] ; Alireza Malektojari [Iran] ; Sara Ghazizadeh [Iran] ; Mehdi Hassaniazad [Iran] ; Parivash Davoodian [Iran] ; Habib Dadvand [Iran] ; Amin Reza Nikpoor [Iran] ; Sara Nikoofal-Sahlabadi [Iran] ; Sara Kahoori [Iran] ; Mojtaba Sepandi [Iran] ; Soheil Hassanipour [Iran] ; Mohammad Fathalipour [Iran] | The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial. |
| 000310 (2021) |
Silvia Molino [Espagne] ; Andrea Pisarevsky [Argentine] ; Fabiana Lopez Mingorance [Argentine] ; Patricia Vega [Argentine] ; Juan Pablo Stefanolo [Argentine] ; Julieta Repetti [Argentine] ; Guillermina Ludue A [Argentine] ; Pablo Pepa [Argentine] ; Juan Ignacio Olmos [Argentine] ; Marcelo Rodriguez Fermepin [Argentine] ; Tatiana Uehara [Argentine] ; Sonia Villapol [États-Unis] ; Tor Savidge [États-Unis] ; Todd Treangen [États-Unis] ; Elisa Viciani [Italie] ; Andrea Castagnetti [Italie] ; Maria Marta Piskorz [Argentine] | Natural tannin extracts supplementation for COVID-19 patients (TanCOVID): a structured summary of a study protocol for a randomized controlled trial. |
| 000338 (2021) |
Florence Rodgers [Royaume-Uni] ; Toby Pepperrell [Royaume-Uni] ; Sarai Keestra [Pays-Bas, Royaume-Uni] ; Victoria Pilkington [Royaume-Uni] | Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs. |
| 000424 (2021) |
Petri J. Vainio [Finlande] ; Pauliina Hietasalo [Finlande] ; Anna-Liisa Koivisto [Finlande] ; Susanna K Ri Inen [Finlande] ; Jari Turunen [Finlande] ; Mika Virtala [Finlande] ; Jouni Vuorinen [Finlande] ; Mika Scheinin [Finlande] | Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial. |
| 000539 (2021) |
H. Rahimi [Iran] ; A. Allahyari [Iran] ; S. Ataei Azimi [Iran] ; M. Kamandi [Iran] ; Z. Mozaheb [Iran] ; F. Zemorshidi [Iran] ; M. Khadem-Rezaiyan [Iran] ; A. Bary [Iran] ; M. Seddigh-Shamsi [Iran] ; M Moeini Nodeh [Iran] | Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: study protocol for a randomized controlled trial. |
| 000565 (2021) |
Iwein Gyselinck [Belgique] ; Laurens Liesenborghs [Belgique] ; Ewout Landeloos [Belgique] ; Ann Belmans [Belgique] ; Geert Verbeke [Belgique] ; Peter Verhamme [Belgique] ; Robin Vos [Belgique] ; W. Janssens [Belgique] | Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial. |
| 000A42 (2020) |
José Meneses Calder N [Mexique] ; Hugo Mendieta Zer N [Espagne, Mexique] ; Srivatsan Padmanabhan [États-Unis] | Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial. |
| 000B52 (2020) |
Eoin Feeney [Irlande (pays)] ; Deborah Wallace [Irlande (pays)] ; Aoife Cotter [Irlande (pays)] ; Willard Tinago [Irlande (pays)] ; Cormac Mccarthy [Irlande (pays)] ; David Keane [Irlande (pays)] ; Rabia Hussain [Irlande (pays)] ; Elena Alvarez Barco [Irlande (pays)] ; Peter Doran [Irlande (pays)] ; Patrick Mallon [Irlande (pays)] | The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial. |
| 000B55 (2020) |
Justin T. Denholm [Australie] ; Joshua Davis [Australie] ; David Paterson [Australie] ; Jason Roberts [Australie, France] ; Susan Morpeth [Nouvelle-Zélande] ; Thomas Snelling [Australie] ; Dominica Zentner [Australie] ; Megan Rees [Australie] ; Matthew O'Sullivan [Australie] ; David Price [Australie] ; Asha Bowen [Australie] ; Steven Y C. Tong [Australie] | The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial. |
| 000B59 (2020) |
Siri Göpel [Allemagne] ; Wolfgang Bethge [Allemagne] ; Peter Martus [Allemagne] ; Florian Kreth [Allemagne] ; Thomas Iftner [Allemagne] ; Stefanie Joos [Allemagne] ; Stefanie Döbele [Allemagne] ; Benjamin Mordmüller [Allemagne] ; Peter Kremsner [Allemagne] ; Thomas Ettrich [Allemagne] ; Thomas Seufferlein [Allemagne] ; Michael Bitzer [Allemagne] ; Nisar Malek [Allemagne] | Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial. |
| 000C41 (2020) |
Prasan Kumar Panda [Inde] ; Arkapal Bandyopadhyay [Inde] ; Budha Charan Singh [Inde] ; Bikram Moirangthem [Inde] ; Gaurav Chikara [Inde] ; Sarama Saha [Inde] ; Yogesh Arvind Bahurupi [Inde] | Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial. |
| 000C43 (2020) |
Ashkan Emadi [États-Unis] ; Joel V. Chua [États-Unis] ; Rohit Talwani [États-Unis] ; S Ren M. Bentzen [États-Unis] ; John Baddley [États-Unis] | Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. |
| 000D98 (2020) |
Julie K. Wright [Canada] ; Darrell H S. Tan [Canada] ; Sharon L. Walmsley [Canada] ; Jennifer Hulme [Canada] ; Erin O'Connor [Canada] ; Carolyn Snider [Canada] ; Ivy Cheng [Canada] ; Adrienne K. Chan [Canada] ; Bjug Borgundvaag [Canada] ; Shelley Mcleod [Canada] ; Michael H. Gollob [Canada] ; Rosemarie J. Clarke [Canada] ; Linda Dresser [Canada] ; Fatima Haji [Canada] ; Tony Mazzulli [Canada] ; Samira Mubareka [Canada] ; Peter Jüni [Canada] ; Dominic Lee [Canada] ; George Tomlinson [Canada] ; Kevin C. Kain [Canada] ; Megan Landes [Canada] | Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada. |
| 000E10 (2020) |
Pradeesh Sivapalan [Danemark] ; Charlotte Suppli Ulrik [Danemark] ; Therese Sophie Lappere [Danemark] ; Josefin Viktoria Eklöf [Danemark] ; Saher Burhan Shaker [Danemark] ; Uffe Christian Steinholtz B Dtger [Danemark] ; Andrea Browatzki [Danemark] ; Christian Niels Meyer [Danemark] ; Ulla M Ller Weinreich [Danemark] ; Christian B. Laursen [Danemark] ; Tor Biering-S Rensen [Danemark] ; Filip Krag Knop [Danemark] ; Jens D. Lundgren [Danemark] ; Jens-Ulrik St Hr Jensen [Danemark] | Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan. |
| 000E11 (2020) |
Pradeesh Sivapalan [Danemark] ; Charlotte Suppli Ulrik [Danemark] ; Rasmus Dahlin Bojesen [Danemark] ; Therese Sophie Lapperre [Danemark] ; Josefin Viktoria Eklöf [Danemark] ; Kjell Erik Julius H Kansson [Danemark] ; Andrea Browatzki [Danemark] ; Casper Tidemansen [Danemark] ; Jon Torgny Wilcke [Danemark] ; Julie Janner [Danemark] ; Vibeke Gottlieb [Danemark] ; Howraman Meteran [Danemark] ; Celeste Porsbjerg [Danemark] ; Birgitte Lindegaard Madsen [Danemark] ; Mia Moberg [Danemark] ; Lars Pedersen [Danemark] ; Thomas Lars Benfield [Danemark] ; Jens Dilling Lundgren [Danemark] ; Filip Krag Knop [Danemark] ; Tor Biering-S Rensen [Danemark] ; Muzhda Ghanizada [Danemark] ; Tine Peick Sonne [Danemark] ; Uffe Christian Steinholtz B Dtger [Danemark] ; Sidse Graff Jensen [Danemark] ; Daniel Bech Rasmussen [Danemark] ; Eva Br Ndum [Danemark] ; Oliver Djurhuus Tupper [Danemark] ; Susanne Wiemann S Rensen [Danemark] ; Gitte Alstrup [Danemark] ; Christian Borbjerg Laursen [Danemark] ; Ulla Weinrich M Ller [Danemark] ; Asger Sverrild [Danemark] ; Jens-Ulrik St Hr Jensen [Danemark] | Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial. |
| 000E27 (2020) |
Berta Grau-Pujol [Espagne, Mozambique] ; Daniel Camprubí [Espagne] ; Helena Marti-Soler [Espagne] ; Marc Fernández-Pardos [Espagne] ; Caterina Guinovart [Espagne] ; Jose Mu Oz [Espagne] | Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial. |
| 000E86 (2020) |
Javed Akram [Pakistan] ; Shehnoor Azhar [Pakistan] ; Muhammad Shahzad [Pakistan] ; Waqas Latif [Pakistan] ; Khalid Saeed Khan [Espagne] | Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial. |
| 000E87 (2020) |
Oriana Nanni [Italie] ; Pierluigi Viale [Italie] ; Bernadette Vertogen [Italie] ; Claudia Lilli [Italie] ; Chiara Zingaretti [Italie] ; Caterina Donati [Italie] ; Carla Masini [Italie] ; Manuela Monti [Italie] ; Patrizia Serra [Italie] ; Roberto Vespignani [Italie] ; Veruska Grossi [Italie] ; Annibale Biggeri [Italie] ; Emanuela Scarpi [Italie] ; Francesca Galardi [Italie] ; Lucia Bertoni [Italie] ; Americo Colamartini [Italie] ; Fabio Falcini [Italie] ; Mattia Altini [Italie] ; Ilaria Massa [Italie] ; Raffaella Gaggeri [Italie] ; Giovanni Martinelli [Italie] | PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial. |
| 000E94 (2020) |
Miriam Saiz-Rodríguez [Espagne] ; Teresa Pe A [Espagne] ; Lourdes Lázaro [Espagne] ; Ángel González [Espagne] ; Andrés Martínez [Espagne] ; José A. Cordero [Espagne] ; Juan T. Vicente [Espagne] ; Fernando Richard [Espagne] ; María Jesús Coma [Espagne] ; Martín De Frutos [Espagne] ; Jorge Labrador [Espagne] ; Ana Pueyo [Espagne] | Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial. |
| 000F27 (2020) |
Magnus Nakrem Lyngbakken [Norvège] ; Jan-Erik Berdal [Norvège] ; Arne Eskesen [Norvège] ; Dag Kvale [Norvège] ; Inge Christoffer Olsen [Norvège] ; Anbj Rg Rangberg [Norvège] ; Christine Monceyron Jonassen [Norvège] ; Torbj Rn Omland [Norvège] ; Helge R Sj [Norvège] ; Olav Dalgard [Norvège] | Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. |
| 001023 (2020) |
Julio Vallejos [Argentine] ; Rodrigo Zoni [Argentine] ; Maria Bangher [Argentine] ; Silvina Villamandos [Argentine] ; Angelina Bobadilla [Argentine] ; Fabian Plano [Argentine] ; Claudia Campias [Argentine] ; Evangelina Chaparro Campias [Argentine] ; Fernando Achinelli [Argentine] ; Hector A. Guglielmone [Argentine] ; Jorge Ojeda [Argentine] ; Fernanda Medina [Argentine] ; Diego Farizano Salazar [Argentine] ; Gerardo Andino [Argentine] ; Natalia E. Ruiz Diaz [Argentine] ; Pablo Kawerin [Argentine] ; Elba Meza [Argentine] ; Silvana Dellamea [Argentine] ; Antonia Aquino [Argentine] ; Victor Flores [Argentine] ; Carolina N. Martemucci [Argentine] ; María Mercedes Vernengo [Argentine] ; Silvina María Martinez [Argentine] ; Juan Emanuel Segovia [Argentine] ; María Gabriela Aguirre [Argentine] | Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial. |
